Sacubitril-valsartan: novel therapy for heart failure.
作者信息
Sehn Evan, McDonald Terrence, Lindblad Adrienne J
机构信息
Doctor of Pharmacy student at the University of Alberta in Edmonton.
Assistant Clinical Professor and Researcher in the Department of Family Medicine at the University of Calgary in Alberta.
出版信息
Can Fam Physician. 2017 Sep;63(9):697.
Abstract
摘要
相似文献
1
Sacubitril-valsartan: novel therapy for heart failure.沙库巴曲缬沙坦：心力衰竭的新型疗法。
Can Fam Physician. 2017 Sep;63(9):697.
2
Initial clinical experience with the first drug (sacubitril/valsartan) in a new class - angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland.在波兰，心力衰竭伴有射血分数降低的患者中，应用新型药物（沙库巴曲缬沙坦）——血管紧张素受体脑啡肽酶抑制剂的初步临床经验。
Kardiol Pol. 2018;76(2):381-387. doi: 10.5603/KP.a2017.0230. Epub 2017 Dec 1.
3
Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction.沙库巴曲缬沙坦对射血分数保留的心力衰竭疗效的Meta分析
Am J Cardiol. 2021 Apr 15;145:165-168. doi: 10.1016/j.amjcard.2021.01.013. Epub 2021 Jan 30.
4
What will be the impact of sacubitril/valsartan in clinical practice?沙库巴曲缬沙坦在临床实践中的影响将会是什么？
J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e88-e90. doi: 10.2459/JCM.0000000000000568.
5
Evolution of functional class, biochemical and echocardiographic parameters and clinical outcomes after sacubitril/valsartan initiation in daily practice.在日常实践中，沙库巴曲缬沙坦起始治疗后心功能分级、生化和超声心动图参数的变化及临床转归。
J Comp Eff Res. 2019 Jul;8(9):685-697. doi: 10.2217/cer-2019-0014. Epub 2019 Jul 10.
6
Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline-Directed Medical Therapy of Heart Failure.沙库巴曲缬沙坦：心力衰竭指南导向药物治疗工具库中的最新药物。
Am J Med. 2017 Jun;130(6):635-639. doi: 10.1016/j.amjmed.2017.02.010. Epub 2017 Mar 9.
7
Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?沙库巴曲缬沙坦会降低B型利钠肽检测在急性心脏护理中的临床效用吗？
Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):321-328. doi: 10.1177/2048872615626355. Epub 2016 Jan 12.
8
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.沙库巴曲缬沙坦治疗期间的 B 型利钠肽：PARADIGM-HF 试验。
J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272. doi: 10.1016/j.jacc.2019.01.018. Epub 2019 Mar 4.
9
Safety of sacubitril/valsartan initiated during hospitalization: data from a non-selected cohort.住院期间起始应用沙库巴曲缬沙坦的安全性：一项非选择性队列研究的数据。
ESC Heart Fail. 2019 Dec;6(6):1161-1166. doi: 10.1002/ehf2.12527. Epub 2019 Nov 8.
10
The safety of sacubitril-valsartan for the treatment of chronic heart failure.沙库巴曲缬沙坦治疗慢性心力衰竭的安全性。
Expert Opin Drug Saf. 2017 Feb;16(2):257-263. doi: 10.1080/14740338.2017.1279144.
引用本文的文献
1
[Not Available].[无可用内容]。
Can Fam Physician. 2021 Sep;67(9):e247-e248. doi: 10.46747/cfp.6709e247.
2
Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction.用于射血分数降低的心力衰竭的钠-葡萄糖协同转运蛋白2抑制剂。
Can Fam Physician. 2021 Sep;67(9):678. doi: 10.46747/cfp.6709678.
3
Quick and painless: 2018 Updates on guideline recommendations.快速且无痛：2018年指南推荐更新
Can Fam Physician. 2019 Nov;65(11):804-806.
本文引用的文献
1
Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension.沙库巴曲缬沙坦（LCZ696）对盐敏感性高血压患者利钠、利尿、血压及N末端B型利钠肽原的影响
Hypertension. 2017 Jan;69(1):32-41. doi: 10.1161/HYPERTENSIONAHA.116.08484. Epub 2016 Nov 14.
2
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.沙库巴曲缬沙坦与依那普利在低于目标剂量时对射血分数降低的心力衰竭的疗效：PARADIGM-HF试验
Eur J Heart Fail. 2016 Oct;18(10):1228-1234. doi: 10.1002/ejhf.580. Epub 2016 Jun 10.
3
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.《加拿大心血管学会心力衰竭指南手册：将指南与临床实践相结合》
Can J Cardiol. 2016 Mar;32(3):296-310. doi: 10.1016/j.cjca.2015.06.019. Epub 2015 Jun 25.
4
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.2014 年加拿大心血管学会心力衰竭管理指南重点更新：贫血、生物标志物和近期治疗试验的影响。
Can J Cardiol. 2015 Jan;31(1):3-16. doi: 10.1016/j.cjca.2014.10.022. Epub 2014 Dec 19.
5
Angiotensin-neprilysin inhibition versus enalapril in heart failure.血管紧张素-脑啡肽酶抑制剂与依那普利治疗心力衰竭的比较。
N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
6
Aldosterone antagonists in systolic heart failure.收缩性心力衰竭中的醛固酮拮抗剂
Can Fam Physician. 2014 Feb;60(2):e104.
7
Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review.B型利钠肽水平在诊断左心室功能不全和心力衰竭中的准确性：一项系统评价
Eur J Heart Fail. 2006 Jun;8(4):390-9. doi: 10.1016/j.ejheart.2005.10.004. Epub 2005 Nov 21.
Zotero 插件